Main competitors
P/E (N) Price to Book (N) PEG (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Dividend Yield (N) Capi.($)
28.52x4.25x2.19x5.78x16.7x21.32x0.55% 58.15B
15.58x1.81x-2.26x3.36x9.06x9.91x0.65% 61.21B
32.09x6.47x0.62x10.84x20.46x24.22x-.--% 39.54B
-46.6x2.12x0.37x2.86x8.43x9.83x3.94% 35.08B
31.36x1.44x-1.06x3.42x10.31x12.13x-.--% 28.68B
17.06x3.13x-4.74x2.86x8.84x8.64x-.--% 21.06B
-5.32x3.13x-0.28x7.01x-4.29x-4.07x-.--% 18.25B
47.8x4.76x0.26x5.06x36.34x33.11x-.--% 16.49B
24.35x3.41x0.02x5.04x13.6x18.93x-.--% 15.87B
-30.98x-5.38x0.73x14.62x-44.25x-46x-.--% 13.2B
-127.4x13047.67x2.68x12.75x-112.98x-127.48x-.--% 12.68B
57.63x23.63x0.54x36.03x50.61x52.1x0.16% 11.1B
15.95x - 0.17x3.43x12.57x15.07x-.--% 10.86B
40.08x - 2.87x - - - -.--% 9.21B
11.79x1.03x0.41x1.8x7.28x9.69x2.85% 6.28B
-117.78x - 7.8x - - - -.--% 5.79B
12.97x1.2x-0.19x2.22x5.74x6.9x1.72% 5.26B
53.27x3.77x-0.68x - - - - 5.05B
24.16x - 1.19x6.39x16.96x20.25x0.43% 4.93B
Average 4.45x 873.50x 0.56x 7.72x 3.46x 4.03x 0.57% 19.93B
Weighted average by Cap. 9.48x 478.89x 0.06x 6.60x 7.50x 8.83x 0.65%
Biopharmaceuticals
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!